Halozyme Therapeutics | Despesas De Vendas E Administração



Selling And Administration Expenses Alterar Data
Acadia Pharmaceuticals USD 130.08M 3.21M 2024-12
Agios Pharmaceuticals USD 51.7M 13.16M 2024-12
Alnylam Pharmaceuticals USD 295.34M 74.35M 2024-12
Amarin USD 36.9M 1.64M 2024-09
Amgen USD 1.88B 253M 2024-12
Baxter International USD 615M 16M 2024-12
Cytokinetics USD 62.34M 5.69M 2024-12
DBV Technologies USD 6.24M 1.32M 2024-09
Eli Lilly USD 2.36B 62.3M 2025-03
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
Indivior 132M 179M 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
MannKind USD 23.97M 56K 2024-12
Pfizer USD 3.01B 1.27B 2025-03
United Therapeutics USD 170.1M 7.6M 2025-03



Halozyme Therapeutics Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.